Posts

Showing posts from November, 2022

Visceral fat: Expert says eat sweet potatoes to tackle belly fat - backed by study - Express

Image
The study concludes: "SPP inhibited body weight gain, visceral fat gain and alleviation of fatty liver symptoms. "In addition, SPP lowered the levels of triglyceride, very small low-density lipoprotein (bad cholesterol) and very low-density lipoprotein in serum. "It is expected that SPP could be used as a functional food material for people with metabolic disorders." It is not possible to know exactly how much visceral fat you have without imaging tests. Adblock test (Why?)

Irish agency warns of risk from Salmonella in duck eggs - Food Safety News

Image
The Food Safety Authority of Ireland (FSAI) has issued a warning about the safety of duck eggs following a recall because of Salmonella. Meadow Park Eggs recalled duck eggs because of the possible presence of Salmonella earlier this month.  Meadow Park Free Range Duck Eggs in a pack size of six with best before dates up to and including Aug. 8 are affected. Irish officials said there was one potentially related illness but further testing was required before a definitive link could be made. They would not say what type of Salmonella was involved. Duck eggs are used as an alternative to chicken eggs in cooking and baking. The FSAI said they should always be handled and cooked with care. They should not be eaten raw or lightly cooked. A duck egg is heavier and larger than a hen's and needs more cooking time. Advice from the agency is for people to only consume duck eggs that have been thoroughly cooked and to avoid using raw duck

Cidara Therapeutics and Melinta Therapeutics Announce Publication of Data from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in The Lancet - Yahoo Finance

Image
Cidara Therapeutics, Inc. Publication details the efficacy and safety of rezafungin dosed once-weekly versus the current of care dosed once-daily Rezafungin PDUFA target action date is scheduled for March 22, 2023 SAN DIEGO and PARSIPPANY, N.J., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX) and Melinta Therapeutics, LLC today announced the peer-reviewed publication of data from the completed pivotal ReSTORE Phase 3 clinical trial evaluating the efficacy and safety of its once-weekly antifungal candidate rezafungin as a potential treatment for candidemia and invasive candidiasis. The data, published in The Lancet titled, " Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial ," demonstrate the statistical noninferiority of rezafungin dosed once-weekly, versus the current standard of care caspofungin, dosed once-daily. "We are proud to

Study Suggests Antibiotic-Resistant Bacteria Could Be More Devious Than We Thought - ScienceAlert

Image
A recent hospital case in Spain suggests antibiotic-resistant bacteria can sometimes migrate from the bowels to the lungs, and possibly back again. Bacteria are known to travel around the human body using routes we know little about, yet it's rare to find a case study where an infection spreads in a clear-cut way. The case in Spain is an exception worth noting. The patient was admitted to an intensive care unit in the municipality of Badalona following a seizure. For 39 days, they were mechanically ventilated while doctors used antibiotics to fight off an infection in their lower airways. On day one, the patient's lungs had shown evidence of a bacteria called Pseudomonas aeruginosa – a common infection in the lungs, urinary tract, and gut – and it was suspected the patient had accidentally breathed in food, saliva, or vomit, possibly during their seizure or following ventilation. On day 12, the patient developed a urinary tract infection, which doctors treated with a differ

Prevalence of selected sexually transmitted infectious agents in a cohort of asymptomatic soldiers in Austria - Parasites & Vectors - Parasites & Vectors

Image
Rowley J, Vander Hoorn SV, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2006. Bull World Health Organ. 2016;97:548–62. Article  Google Scholar  Korzeniewski K. Sexually transmitted infections among army personnel in the military environment. Sex Trans Infect. 2012;71:165–82. Google Scholar  Gaydos JC, McKee KT, Faix DJ. Sexually transmitted infections in the military: new challenges for an old problem. Sex Transm Infect. 2015;91:536–7. Article  PubMed  Google Scholar  Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M. Should we be testing for urogenital Mycoplasma hominis , Ureaplasma parvum and Ureaplasma urealyticum in men and women?—A position statement from the European STI Guidelines

Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data - The Lancet

Introduction Typhoid fever, a systemic infection caused by Salmonella enterica serovar Typhi ( S Typhi), is transmitted through contaminated food and water. In 2019, there were an estimated 9·24 million cases of typhoid fever globally and 110 000 deaths, with the greatest burden in low-income and middle-income countries (LMICs) in sub-Saharan Africa and Asia. 1 Institute for Health Metrics and Evaluation Typhoid fever—level 4 cause. Increasing antimicrobial resistance, including the emergence of extensively drug resistant isolates, limits treatment options in many settings and has created an urgency to adopt effective preventive measures. 2 Carey ME McCann NS Gibani MM Typhoid fever control in the 21st century: where are we now?. In 2017, WHO recommended routine use of typhoid conjugate vaccine in children aged 6 months and older in endemic settings. 3 WHO Typhoid vaccines: WHO position paper, March 2018—recommendations. Since then, excellent typhoid conjugate vaccine efficacy has